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Abstract
Background: The present therapeutic agents for the treatment of pain, inflammation and pyrexia are not very effective
and accompanied by various side effects. Therefore, new effective agents are the most wanted. The present study
investigates the anti-nociceptive, anti-inflammatory and antipyretic activities of crude methanol extract of Hypericum
oblongifolium.
Methods: In vivo acetic acid induced writhing and hot plate tests were used for antinociceptive effects at 100, 200 and
300 mg/kg i.p. The anti-inflammatory and antipyretic potential of methanol extract were tested in carrageenan induced
paw edema in mice and yeast induced hyperthermia respectively.
Results: The extract doses of 100, 200 and 300 mg/kg i.p. revealed significant inhibitory effect (P < 0.001) in acetic
acid induced writhing test. Pretreatment of extract at doses of 100, 200 and 300 mg/kg i.p. produced significant
anti-inflammatory effect (P < 0.001) in the carrageenan induced paw edema. The methanol extract also showed
significant antipyretic effect in yeast induced hyperthermia in mice during various assessment times.
Conclusions: The methanol extract of H. oblongifolium showed significant anti-nociceptive, anti-inflammatory and
antipyretic effects in various animal models and thus validates the traditional uses of the plant in said conditions.
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Background
Pain, inflammation and pyrexia can result in unrelenting
symptoms, misery, stress and sometimes disablement for
the sufferer. Allopathic medicine uses drug treatments to
decrease the inflammation and pyrexia as well as reduce
the pain by blocking various inflammatory mediators
especially the prostaglandins, leukotrienes, cytokines and
histamine. However, these medications often cause side
effects such as stomach bleeding, bone demineralisation,
kidney damage and nutritional deficiencies [1, 2]. The use
of complementary and alternative medicine has been
shown to produce beneficial effect in the management of
various painful inflammatory conditions [3, 4] and several
natural remedies are available that are often as effective as
drugs without the side effects [5, 6]. Thus there is an
ample scope for new natural medicines to combat differ-
ent pathological conditions associated with pain, inflam-
mation and pyrexia.
Hypericum, is a large genus of the family Hypericacea
and consists of herbs or shrubs that grow widely in the
temperate regions. Useful drugs, dyes, pigments, timbers,
gums and resins have been isolated from its different mem-
bers [7]. This genus is widely studied for anti-depressant,
anti-microbial, antioxidant, antiviral, anxiolytic, anticancer,
anti-inflammatory and anti-ulcerogenic activities. Several
species of this genus especially Hypericum perforatum [8],
Hypericum caprifoliatum [9, 10], Hypericum polyanthe-
mum [11, 12], and Hypericum grandifolium [13, 14] were
extensively studied for their utility in different diseases like
depression, seasonal effective disorder, HIV and hepatitis-C
infection, obsessive compulsive disorder, as well as other
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pathological conditions associated with pain and inflamma-
tion. Their use in these conditions has been validated by
using a number of different animal and in vitro models.
Hypericum oblongifolium Wall. (family: Hypericacea),
is a 6–12 m high erect evergreen shrub that grows at an
altitude of 5000-6000 ft and is common in China and
Himalaya [15]. This plant has been traditionally used for
the treatment of hepatitis, nasal hemorrhage, gastric ulcer,
external wounds, sedative, antispasmodic, antiseptic and
as a remedy for sting of bees and dog bites [16, 17]. H.
oblongifolium has been tested for chymotrypsin [15] and
urease inhibition [18], antioxidant, anti-glycation, anti-
lipid peroxide inhibition [19], antispasmodic, broncho-
dilator, blood pressure lowering [16], anti-ulcer [20]
and anti-proliferative activities [17]. Phytochemical
analysis showed that H. oblongifolium contained flavo-
noids, saponins and tannins [16]. Recently, various
chemical compounds have been isolated from this plant
and include triterpenes like hyperinols A and B [15], flavo-
noids like quercetin, myricetin, rhamnetin, kaempferol,
luteolin [21], 18-β-H-urs-20 (30)-en-3β-ol-28-oic acid, tet-
racosyl 3-(3,4-dihydroxyphenyl) acrylate, shikimic acid, 1-
octatriacontanol, hexacosyl tetracosanoate, β-sitosterol
and β-sitosterol 3-O-β-D-glucopyranoside [17], xanthones
like hypericorin-C, hypericorin-D, 3,4-dihydroxy-5-meth-
oxyxanthone, along with 2,3-dimethoxyxanthone, 3,4-di-
hydroxy-2-methoxyxanthone, 3,5-dihydroxy-1-methoxyx
anthone, 3-acetylbetulinic acid, 10-H-1,3-dioxolo [4,5-b]-
xanthen-10-one, 3-hydroxy-2-methoxyxanthone, 3,4,5-tri-
hydroxyxanthone and betulinic acid [20]. More recently
our research group reported a new antioxidant i.e. folicitin
from H. oblongifolium [22].
Keeping in view the potential pain and inflammation
relieving properties of the genus Hypericum, the present
study has been attempted to explore the Hypericum oblon-
gifolium methanol extract (HOME) for its prospective
analgesic, anti-inflammatory and anti-pyretic activities.
Methods
Chemicals
Diclofenac sodium (Suzhou Ausun Chemical Co, Lit.,-
China), acetic acid, Tramadol (Searle Pakistan Ltd.), carra-
geenan (Sigma Lambda, USA), Brewer’s yeast (Merck
Germany), paracetamol (Tianjin Bofa Pharmaceutical Co,
Lit., China), commercial grade methanol was obtained
from Haq chemicals Peshawar. Sterile normal saline was
used in all experiments as control while the methanol
extract was prepared in normal saline.
Animals
BALB/c mice of either sex weighing 25–30 gm were pur-
chased from the Pharmacology section of the Department
of Pharmacy, University of Peshawar, Pakistan. The animals
were maintained in a 12 h light/dark cycle at 22 ± 2 °C.
Access to food and water was ad libitum. Experiments on
animals were performed between 9:00 am and 3:00 pm.
The experiment protocols were approved by the Ethical
Committee of the Department of Pharmacy, University of
Peshawar, Pakistan.
Plant material
Whole plant of Hypericum oblongifolium was collected
in April and May, 2011, from Bara Gali, Abbottabad,
Khyber Pakhtunkhwa. The plant was identified by Prof.
Dr. Muhammad Ibrar of the Department of Botany,
University of Peshawar, Pakistan and a voucher specimen
(08823) was deposited in the herbarium of the same
department. The powdered plant material was extracted
in 20 % methanol.
Antinociceptive activity
Acetic acid induced writhing test
Animals were divided into five treatment groups with six
animals per group. Group I was injected with normal saline
(10 ml/kg) as control, Group II received diclofenac sodium
(10 mg/kg) while groups III, IV and V were injected with
100, 200 and 300 mg/kg i.p. of HOME respectively. After
30 min of treatment with saline, diclofenac sodium and
extract, the animals were injected with 1 % acetic acid i.p.
The number of abdominal constrictions (writhes) were
counted after 5 min of acetic acid injection for a period of
10 min [23].
Hot plat test
Animals were subjected to a pretest on hot plate (Havard
apparatus) maintained at 55 ± 0.1 °C. During pre-testing,
the animals having a latency time greater than 15 s were
rejected. The mice were divided into five treatment groups
with six animals per group. Group I was treated with sa-
line (10 ml/kg), group II with Tramadol (30 mg/kg i.p)
while groups III, IV and V were treated with 100, 200 and
300 mg/kg i.p HOME respectively. After 30 min of treat-
ment, the animals were placed on the hot plate and the
latency time (time for which mouse remains on the hot
plate without licking or flicking of hind limb or jumping)
was measured in sec after 30, 60 and 90 min. In order to
prevent tissue damage, a cut-off time of 30 s was imposed
for all the animals [23, 24]. The percent analgesia was
calculated using the following formula:
% Analgesia ¼ Test latency – Control latencyð Þ
 Cut off time – Control latencyð Þ  100
Anti-inflammatory activity
Animals were randomly divided into five treatment
groups with six animals per group. Group I was treated
with normal saline (10 ml/kg), group II with diclofenac
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sodium (10 mg/kg) and the rest of groups i.e. III, IV and
V were treated with HOME at doses of 100, 200, and
300 mg/kg, i.p respectively. After 30 min of treatment,
carrageenan (1 %, 0.05 ml) was injected subcutaneously
in the sub plantar tissue of the right hind paw of each
mouse. The inflammation was measured immediately
after the first dose and then after 1, 2, 3 and 4 h of
carrageenan using a digital plethysmometer (LE 7500
plan lab S.L). The average foot swelling readings from
the drug and standard treated animals was compared
with that of control [23, 24]. The percent inhibition was
determined according to the formula.
Percent inhibition ¼ A – B=A  100
Where A is the paw volume of control and B is the
paw volume of the tested group.
Antipyretic test
Animals were divided into five treatment groups with six
animals per group. All animals were fasted overnight but
allowed free access to drinking water. The normal rectal
temperature of each mouse was recorded using a digital
thermometer and then pyrexia was induced in all mice
by injecting 20 % aqueous suspension of Brewer’s yeast
(10 ml/kg, s.c). After 24 h, rectal temperature of each
mouse was recorded. The induction of pyrexia was con-
firmed by a rise in temperature of more than 0.5 °C and
animals showing a rise in temperature less than 0.5 °C
were excluded from the experiment [23, 25]. Group I
received saline as a negative control, Group II received
paracetamol (150 mg/kg) as a standard drug while the
remaining groups III, IV and V received 100, 200 and
300 mg/kg i.p of HOME respectively. After drugs
administration, rectal temperature was again recorded
periodically at 1, 2, 3, and 4 h.
Statistical analysis
Data were expressed as mean ± SEM. The statistical sig-
nificance of the differences between groups was tested
by one-way analysis of variance (ANOVA) followed by
Dunnett’s post hoc test using GraphPad Prism 5 (Graph-
Pad Software Inc. San Diego CA, USA).
Results
Antinociceptive effect
Effect of acetic acid induced test
As shown in Fig. 1, HOME at all the tested doses (100,
200 and 300 mg/kg) significantly (P < 0.001) amelio-
rated the acetic acid induced writhes. The inhibition
was comparable to that of standard, diclofenac sodium
(P < 0.001). Maximum percent inhibition (95.98 %) of
acetic acid induced pain was observed at 300 mg/kg
dose of HOME.
Hot plate test
As shown in Fig. 2, no significant effect was observed in
the latency time by HOME except at a dose of 200 mg/kg
(P < 0.05) after 60 min as compared to saline treated
group. Significant increase (P < 0.001) in the latency time
was noticed with the standard opioid analgesic (Tramadol)
after 30, 60 and 90 min.
Anti-inflammatory activity
As shown in Fig. 3, significant protection (P < 0.001)
from carrageenan induced inflammation was exhibited
by HOME at doses of 100, 200 and 300 as compared to
saline treated group. Likewise the standard, diclofenac
sodium also produces significant reduction (P < 0.001) of
carrageenan induced paw edema in the four hours
testing paradigm.
Antipyretic test
As shown in Fig. 4, HOME provided significant protection
against hyperthermia induced by yeast after 1 h of
Fig. 1 Antinociceptive activity of different doses of Hypericum oblongifolium methanol extract (HOME) (100, 200 and 300 mg/kg) in acetic acid
induced writhing assay. The total number of writhes was expressed as mean ± SEM. ANOVA followed by Dunnett’s post hoc test. ***P < 0.001
compared to saline treated group, n = 6 mice/group
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treatment at doses of 200 and 300 mg/kg (P < 0.05). Simi-
larly, significant antipyretic effect was observed with all the
tested doses i.e. 100, 200 and 300 mg/kg after 2 h (P < 0.05,
P < 0.01), 3 h (P < 0.01) and 4 h (P < 0.001) of treatment.
Likewise, the standard, paracetamol significantly de-
creased the febrile response after 2–3 h (P < 0.01) and
4 h (P < 0.001) of treatment.
Discussion
The present study evaluated the analgesic, anti-
inflammatory and antipyretic activities of the metha-
nol extract of H. oblongifolium.
Acetic acid induced abdominal constriction assay is a
well recommended protocol in evaluating medicinal agents
for their peripheral analgesic activity [26, 27]. In this
paradigm, pain is induced by the liberating endogenous
substances especially the prostaglandins through the action
of the constitutive enzyme cyclooxygenase-1 (COX-1) and
its isoform COX-2. Induction of this mechanism through
COX enzymes and stimulation of these sensory pathways
in the mouse peritoneum incites a viscero-somatic reflex
and the abdominal constrictions (writhing) [28]. The acetic
acid induced writhing method is sensitive to analgesics and
sensory afferents in the peritoneum carry α1/2-adreno-
ceptors, β-adrenoceptors and opioid receptors on their
terminals. When activated by appropriate agonists,
these receptors depress the generation of pain impulses
[29, 30]. Regarding the results of our extract in acetic
acid-induced abdominal constriction assay, a prominent
inhibition of writhing reflex was observed. These findings
strongly recommend that HOME has peripheral analgesic
activity and their mechanisms of action might be mediated
through inhibition of local peritoneal receptors or inhib-
ition of cyclooxygenase enzymes. The writhing test how-
ever is non-specific in nature as it does not exactly
indicate the involvement of central or peripheral mechan-
ism. On the other hand, the hot plate method involves
spinal reflex and may be considered as a suitable model
for the determination of central anti-nociceptive mechan-
ism [31–33]. Although, in this study, HOME produce
significant analgesic effect in the hot plate test only at a
dose of 200 mg/kg after 60 min (P < 0.05), however, a non-
statistical significant protection against thermal induced
nociception was observed at doses of 300 mg/kg (35.9 %)
after 30 min, 100 mg/kg (13.9 %) and 300 mg/kg (34.9 %)
after 60 min and for all the tested doses after 90 min i.e.
100 mg/kg (47.9 %), 200 mg/kg (71.8 %) and 300 mg/kg
(51.6 %) (Fig. 2). In comparison the standard opioid
analgesic i.e. tramadol produced significant analgesic effect
(P < 0.001) after 30, 60 and 90 min.
Carrageenan-induced paw edema is a well established
animal model to assess the anti-inflammatory effect of
natural products as well as synthetic chemical compounds.
Carrageenan-induced edema in paw is a biphasic event; the
initial phase (1 or 1.5 h) is predominately a non-phagocytic
edema followed by a second phase (2–5 h) with increased
Fig. 2 Antinociceptive activity of Hypericum oblongifolium methanol extract (HOME) (100, 200 and 300 mg/kg) in the hot plate test. Each bar
represents mean ± SEM. ANOVA followed by Dunnett’s post hoc test. *P < 0.05, ***P < 0.001. n = 6 mice/group
Fig. 3 Anti-inflammatory activity of Hypericum oblongifolium methanol extract (HOME) (100, 200 and 300 mg/kg) in the carrageenan induced paw
edema in mice. Each bar represents mean ± SEM. ANOVA followed by Dunnett’s post hoc test. ***P < 0.001. n = 6 mice/group
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edema formation that remained up to 5 h. The initial phase
has been attributed to the release of various mediators in-
cluding histamine, serotonin and bradykinin while the late
phase or second phase edema has been shown to be caused
by overproduction of prostaglandins [34–36]. The result of
pre-treatment of HOME demonstrated that the extract is
effective in alleviating inflammation during the entire study
duration. Significant protection against carragennan in-
duced paw edema was afforded by the 100, 200 and
300 mg/kg doses of HOME after 1 h (10 %, 13.5 %, 21.4 %),
2 h (21 %, 30.8 %, 38.3 %), 3 h (30.6 %, 50.6 %, 66.2 %) and
4 h (28.8 %, 43.6 %, 54.1 %) of treatment. The ability to
decrease paw inflammation in mice by all the tested doses
of HOME was significantly (P < 0.001) comparable to that
of the standard, diclofenac sodium (10 mg/kg) (Fig. 3).
Subcutaneous injection of Brewer’s yeast induces pyrexia
by increasing the synthesis of prostaglandins and is consid-
ered as a useful test for screening of plants materials as
well as synthetic drugs for their antipyretic effect [37, 38].
The inhibition of prostaglandin synthesis among other
mediators can be regarded as a possible mechanism of
antipyretic action like that of paracetamol which inhibits
the synthesis of prostaglandin by blocking the COX
enzyme activity [39, 40]. In this study, the intraperitoneal
administration of HOME significantly attenuated the
hyperpyrexia induced by yeast in mice. All the doses of
HOME (100, 200 and 300 mg/kg) were able to reduced the
febrile response and the protection is comparable to the
standard paracetamol especially after 2 h and remained
effective throughout the study duration (4 h).
Studies showed that H. oblongifolium contains xan-
thones which possess strong in vitro anti-inflammatory
[41] and anti-ulcer [20] activities by inhibiting the respira-
tory burst of neutrophils and urease respectively. Luteolin
and myricetin, which are the most abundant flavonoid
aglycones along with quercetin, rhamnetin, and kaemp-
ferol present in H. oblongifolium [21] are known to have
analgesic [42], anti-inflammatory [43] and antipyretic [44]
activities. Moreover, strong antioxidants including folicitin
[22] and quercetin have been isolated from H. oblongifo-
lium and antioxidants are able to reduce pain, pyrexia and
inflammation in both animal models [45–47] as well as in
humans [48, 49]. Furthermore, other Hypericum species
including the widely used official medicine, Hypericum
perforatum are reported to have strong antidepressant,
antinociceptive, antiviral, antimicrobial, antipyretic, anti-
inflammatory and healing properties [50].
Conclusions
H. oblongifolium methanol extract was evaluated for its
anti-nociceptive, anti-inflammatory, and antipyretic poten-
tial. The crude extract possessed significant peripheral
analgesic activity as well as attenuated the carrageenan in-
duced inflammation and yeast induced pyrexia.
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